Thyroid, Thymus, Parathyroid Sarcode NDC 83027-0067

NDC codes

FDA NDC Directory

Product NDC (as listed)83027-0067Labeler and product segments. Claims need a package NDC.

Product NDC at billing width83027-0067Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
83027-0067-1	83027006701	60 mL in 1 BOTTLE, SPRAY (83027-0067-1)Marketed from Apr 18, 2023

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Thyroid, Thymus, Parathyroid Sarcode
Generic name (nonproprietary): thymus (bovine), thyroidinum (bovine), parathyroid gland (bovine)
Active ingredients: Bos taurus thymus — 6 [hp_X]/mLThyroid, Bovine — 6 [hp_X]/mLBos taurus parathyroid gland — 12 [hp_X]/mL
Dosage form: Spray
Route: Oral
Labeler: Nutritional Specialties, Inc.
Product type: Over-the-counter drug
Marketing category: Unapproved homeopathic
Marketing start: Apr 18, 2023
Listing expires: Dec 31, 2026
Identifiers: Product ID 83027-0067_5eb17fba-83f8-4c52-b08f-226d8af8a207SPL ID 5eb17fba-83f8-4c52-b08f-226d8af8a207SPL set ID 57b87cda-68fd-4eb3-88c2-20cb9f3db0d5UNII 8XEJ88V2T8, MN18OTN73W, SMV71DDI4TUPC 0649818080264

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N483027006701 followed by a unit qualifier and the quantity

Package 83027-0067-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 18, 2023.

Indications (excerpt from the label)

INDICATIONS: Provides specific sarcode support for the thyroid, thymus and parathyroid.† †Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)